Pesquisas alternativas:
axons develop » lions develop (Expandir a Pesquisa), baboons develop (Expandir a Pesquisa), reasons develop (Expandir a Pesquisa)
disease level » disease levels (Expandir a Pesquisa), disease liver (Expandir a Pesquisa), disease like (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa), develop age (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
drug axons » drug alone (Expandir a Pesquisa), drug among (Expandir a Pesquisa), drug along (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
axons develop » lions develop (Expandir a Pesquisa), baboons develop (Expandir a Pesquisa), reasons develop (Expandir a Pesquisa)
disease level » disease levels (Expandir a Pesquisa), disease liver (Expandir a Pesquisa), disease like (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa), develop age (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
drug axons » drug alone (Expandir a Pesquisa), drug among (Expandir a Pesquisa), drug along (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
1
Por Okparavero, Aghogho A, Tighiouart, Hocine, Krishnasami, Zipporah, Wyatt, Christina M, Graham, Hiba, Hellinger, James, Inker, Lesley A
Publicado em 2013
“... antiretroviral drug dosing for level of kidney function in 200 HIV-positive patients on stable antiretroviral...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Inui, Takashi, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao
Publicado no Arthritis Res Ther (2017)
“... TNF level, serum infliximab level, and disease activity were compared between the three classes...”Publicado no Arthritis Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... and was related to serum and cerebrospinal fluid drug levels. Repeated 2-week treatment with risperidone...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Publicado no Rheumatol Ther (2018)
“... response at the 20% improvement level (ACR20) and Clinical Disease Activity Index (CDAI) ≤ 10 at week 12...”Publicado no Rheumatol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Schub, David, Assmann, Gunter, Sester, Urban, Sester, Martina, Schmidt, Tina
Publicado no Arthritis Res Ther (2018)
“... their levels and functionality were impacted by disease-modifying antirheumatic drugs (DMARDs). A polyclonal...”Publicado no Arthritis Res Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Papangkorn, Kongnara, Higuchi, John W., Brar, Balbir, Higuchi, William I.
Publicado no J Ocul Pharmacol Ther (2018)
“... and in plasma after single administrations of DSP-Visulex. The drug in eye tissues and plasma was analyzed...”Publicado no J Ocul Pharmacol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Kothari, Mansi M, Nguyen, Douglas L, Parekh, Nimisha K
Publicado no World J Gastrointest Pharmacol Ther (2017)
“... and efficacious therapies for inflammatory bowel disease (IBD). The development of therapeutic drug monitoring...”Publicado no World J Gastrointest Pharmacol Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“... the diseased anterior ocular tissue, generate high drug levels, and maintain prolonged and effective...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... clozapine dose or level, or only as remedial treatment. In this review, we examine the relevant literature...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Lariosa-Willingham, Karen D., Rosler, Elen S., Tung, Jay S., Dugas, Jason C., Collins, Tassie L., Leonoudakis, Dmitri
Publicado no BMC Neurosci (2016)
“... of lost and damaged myelin of the central nervous system (CNS). Development of new drugs that stimulate...”Publicado no BMC Neurosci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Kim, Tiffany, Jancel, Timothy, Kumar, Parag, Freeman, Alexandra F.
Publicado no J Clin Pharm Ther (2015)
“... isavuconazole and tacrolimus there are no recommendations on dose-adjustment when these drugs are given...”Publicado no J Clin Pharm Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)
“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
14
“...Nearly all patients with end-stage renal disease develop hyperphosphatemia. These patients...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Andrés-Guerrero, Vanessa, Perucho-González, Lucía, García-Feijoo, Julián, Morales-Fernández, Laura, Saenz-Francés, Federico, Herrero-Vanrell, Rocío, Júlvez, Luis Pablo, Llorens, Vicente Polo, Martínez-de-la-Casa, José María, Konstas, Anastasios-Georgios P.
Publicado no Adv Ther (2016)
“... levels. In this article we review current perspectives on the use of anti-VEGF drugs as adjuvant therapy...”Publicado no Adv Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Soares, Holly D., Gasior, Maciej, Toyn, Jeremy H., Wang, Jun-Sheng, Hong, Quan, Berisha, Flora, Furlong, Michael T., Raybon, Joseph, Lentz, Kimberley A., Sweeney, Francis, Zheng, Naiyu, Akinsanya, Billy, Berman, Robert M., Thompson, Lorin A., Olson, Richard E., Morrison, John, Drexler, Dieter M., Macor, John E., Albright, Charlie F., Ahlijanian, Michael K., AbuTarif, Malaz
Publicado no J Pharmacol Exp Ther (2016)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Cummings, Jeffrey, Aisen, Paul S., DuBois, Bruno, Frölich, Lutz, Jack, Clifford R., Jones, Roy W., Morris, John C., Raskin, Joel, Dowsett, Sherie A., Scheltens, Philip
Publicado no Alzheimers Res Ther (2016)
“... given the realities and challenges of AD drug development, with a focus on disease-modifying therapies...”Publicado no Alzheimers Res Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Hubbard, Jonathan J., Laurenzana, Elizabeth M., Williams, D. Keith, Gentry, W. Brooks, Owens, S. Michael
Publicado em 2011
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Toyn, Jeremy H., Boy, Kenneth M., Raybon, Joseph, Meredith, Jere E., Robertson, Alan S., Guss, Valerie, Hoque, Nina, Sweeney, Francis, Zhuo, Xiaoliang, Clarke, Wendy, Snow, Kimberly, Denton, R. Rex, Zuev, Dmitry, Thompson, Lorin A., Morrison, John, Grace, James, Berisha, Flora, Furlong, Michael, Wang, Jun-Sheng, Lentz, Kimberly A., Padmanabha, Ramesh, Cook, Lynda, Wei, Cong, Drexler, Dieter M., Macor, John E., Albright, Charlie F., Gasior, Maciej, Olson, Richard E., Hong, Quan, Soares, Holly D., AbuTarif, Malaz, Ahlijanian, Michael K.
Publicado no J Pharmacol Exp Ther (2016)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Kerr, Alastair G., Tam, Lawrence C. S., Hale, Ashley B., Cioroch, Milena, Douglas, Gillian, Agkatsev, Sarina, Hibbitt, Olivia, Mason, Joseph, Holt-Martyn, James, Bataille, Carole J. R., Wynne, Graham M., Channon, Keith M., Russell, Angela J., Wade-Martins, Richard
Publicado no J Pharmacol Exp Ther (2017)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo